Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Warts Therapeutics Market Size Changed, over the years?

The market for warts therapeutics has seen a consistent expansion over the past few years. The sector’s size is predicted to increase from $1.96 billion in 2024 to $2.03 billion in 2025, marking a compound annual growth rate (CAGR) of 3.6%. The historical period’s growth can be attributed to factors such as the usage of salicylic acid, advancements in cryotherapy, progression of topical treatments, surgical interventions, and the advent of immunotherapy.

How Much Will the Warts Therapeutics Market Be Worth in 2029?

The market size for warts therapeutics is projected to experience consistent growth in the coming years, reaching a valuation of $2.4 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 4.3%. The expected growth during the forecast period is due to the development of precision medicine for HPV, innovations in laser therapy, hybrid therapies, advancements in digital health, and initiatives to improve healthcare accessibility. The upcoming trends during this period include focusing on targeted antiviral treatments, gene editing studies, the introduction of biodegradable delivery systems, and a shift towards psychodermatology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11959&type=smp

Which is the Largest Company in the Warts Therapeutics Market?

Major companies operating in the warts therapeutics market include GlaxoSmithKline plc, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Prestige Consumer Healthcare Inc., Maruho Co. Ltd, Taro Pharmaceutical Industries Ltd, Aclaris Therapeutics Inc., Novan Inc, Scholl’s Wellness Co, AIM ImmunoTech Inc., Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Nielsen BioSciences Inc., RXi Pharmaceuticals, Phio Pharmaceuticals Corp., MedCara Pharmaceuticals, KinoPharma Inc., pHion Therapeutics, Compound W, Duofilm, Curad Mediplast, Emblation Ltd.

What Are the Main Market Drivers in the Warts Therapeutics Industry?

The emphasis on wart vaccinations is set to spur the wart therapeutics market’s growth. Vaccination entails injecting a vaccine into the body to produce antibodies to fight infections and associated diseases. Warts are a result of the human papillomavirus (HPV). The use of a therapeutic or preventative vaccine disallows wart formation, pushing sales in the wart therapeutics market. For example, the World Health Organization, based in Switzerland and focusing on international public health, reported an impressive decline in the number of unvaccinated children, or zero-dose children, from 18.1 million in 2021 to 14.3 million in 2022. In tandem, the global coverage for the primary dose of the human papillomavirus (HPV) vaccine in girls surged from 16% in 2021 to 21% in 2022. Consequently, the emphasis on wart vaccinations is fueling the expansion of the wart therapeutics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11959&type=smp

How Is the Warts Therapeutics Market Segments Structured?

The warts therapeutics market covered in this report is segmented –

1) By Type: Common Warts, Genital Warts, Flat Warts, Other Types

2) By Treatment: Physical Destruction, Immunomodulation, Chemical Destruction

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Common Warts: Typically Appear On Hands, Fingers, And Elbows, Caused By Human Papillomavirus (HPV) Types 2 And 4

2) By Genital Warts: Occur In The Genital And Anal Areas, Primarily Caused By HPV Types 6 And 11

3) By Flat Warts: Smaller And Smoother Than Common Warts, Commonly Found On The Face, Neck, And Arms

4) By Other Types: Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose), Various HPV Types Can Cause These Warts

What Strategic Trends Are Transforming the Warts Therapeutics Market?

In the wart therapeutics market, product innovation is becoming a notable trend as companies strive to maintain their market position through the creation of novel treatments. For instance, Verrica Pharmaceuticals Inc., a dermatology therapeutics company based in the US, revealed in February 2023 that its resubmitted New Drug Application (NDA) for VP-102, a cure for molluscum contagiosum (a type of wart), has been approved by the FDA (The United States Food and Drug Administration) and assigned a Prescription Drug User Fee Act (PDUFA) number. The drug VP-102, a patented combination of drug-device, delivers cantharidin (0.7% w/v) through an applicator that is used once for precise topical dosing and targeted administration in adherence with good manufacturing practices (GMP).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Which Global Regions Offer the Highest Growth in the Warts Therapeutics Market?

North America was the largest region in the warts therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the warts therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11959

This Report Delivers Insight On:

1. How big is the warts therapeutics market, and how is it changing globally?

2. Who are the major companies in the warts therapeutics market, and how are they performing?

3. What are the key opportunities and risks in the warts therapeutics market right now?

4. Which products or customer segments are growing the most in the warts therapeutics market?

5. What factors are helping or slowing down the growth of the warts therapeutics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model